210 related articles for article (PubMed ID: 35740990)
1. New Phenylglycinamide Derivatives with Hybrid Structure as Candidates for New Broad-Spectrum Anticonvulsants.
Jakubiec M; Abram M; Zagaja M; Andres-Mach M; Szewczyk A; Latacz G; Szulczyk B; Socała K; Nieoczym D; Wlaź P; Metcalf CS; Wilcox K; Kamiński RM; Kamiński K
Cells; 2022 Jun; 11(12):. PubMed ID: 35740990
[TBL] [Abstract][Full Text] [Related]
2. The Search for New Anticonvulsants in a Group of (2,5-Dioxopyrrolidin-1-yl)(phenyl)Acetamides with Hybrid Structure-Synthesis and In Vivo/In Vitro Studies.
Abram M; Jakubiec M; Rapacz A; Mogilski S; Latacz G; Kamiński RM; Kamiński K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233618
[TBL] [Abstract][Full Text] [Related]
3. Identification of New Compounds with Anticonvulsant and Antinociceptive Properties in a Group of 3-substituted (2,5-dioxo-pyrrolidin-1-yl)(phenyl)-Acetamides.
Abram M; Jakubiec M; Rapacz A; Mogilski S; Latacz G; Szulczyk B; Szafarz M; Socała K; Nieoczym D; Wyska E; Wlaź P; Kamiński RM; Kamiński K
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884898
[TBL] [Abstract][Full Text] [Related]
4. Multitargeted Compounds Derived from (2,5-Dioxopyrrolidin-1-yl)(phenyl)-Acetamides as Candidates for Effective Anticonvulsant and Antinociceptive Agents.
Abram M; Rapacz A; Mogilski S; Latacz G; Lubelska A; Kamiński RM; Kamiński K
ACS Chem Neurosci; 2020 Jul; 11(13):1996-2008. PubMed ID: 32479058
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric synthesis and in vivo/in vitro characterization of new hybrid anticonvulsants derived from (2,5-dioxopyrrolidin-1-yl)phenylacetamides.
Abram M; Rapacz A; Latacz G; Szulczyk B; Kalinowska-Tłuścik J; Otto-Ślusarczyk D; Struga M; Kamiński RM; Kamiński K
Bioorg Chem; 2021 Apr; 109():104751. PubMed ID: 33647745
[TBL] [Abstract][Full Text] [Related]
6.
Gunia-Krzyżak A; Żesławska E; Słoczyńska K; Żelaszczyk D; Sowa A; Koczurkiewicz-Adamczyk P; Popiół J; Nitek W; Pękala E; Marona H
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575479
[TBL] [Abstract][Full Text] [Related]
7. KA-11, a Novel Pyrrolidine-2,5-dione Derived Broad-Spectrum Anticonvulsant: Its Antiepileptogenic, Antinociceptive Properties and in Vitro Characterization.
Socała K; Mogilski S; Pieróg M; Nieoczym D; Abram M; Szulczyk B; Lubelska A; Latacz G; Doboszewska U; Wlaź P; Kamiński K
ACS Chem Neurosci; 2019 Jan; 10(1):636-648. PubMed ID: 30247871
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Anticonvulsant Properties of New 3,3-Diphenyl-2,5-dioxo-pyrrolidin-1-yl-acetamides and 3,3-Diphenyl-propionamides.
Obniska J; Rapacz A; Rybka S; Góra M; Żmudzki P; Kamiński K
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28317156
[TBL] [Abstract][Full Text] [Related]
9. New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.
Kamiński K; Zagaja M; Rapacz A; Łuszczki JJ; Andres-Mach M; Abram M; Obniska J
Bioorg Med Chem; 2016 Feb; 24(4):606-18. PubMed ID: 26746343
[TBL] [Abstract][Full Text] [Related]
10. Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Gunia-Krzyżak A; Żelaszczyk D; Rapacz A; Żesławska E; Waszkielewicz AM; Pańczyk K; Słoczyńska K; Pękala E; Nitek W; Filipek B; Marona H
Bioorg Med Chem; 2017 Jan; 25(2):471-482. PubMed ID: 27876250
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.
Kamiński K; Rapacz A; Łuszczki JJ; Latacz G; Obniska J; Kieć-Kononowicz K; Filipek B
Bioorg Med Chem; 2015 May; 23(10):2548-61. PubMed ID: 25868743
[TBL] [Abstract][Full Text] [Related]
12. KA-104, a new multitargeted anticonvulsant with potent antinociceptive activity in preclinical models.
Kamiński K; Mogilski S; Abram M; Rapacz A; Latacz G; Szulczyk B; Walczak M; Kuś K; Matyjaszczyk K; Kamiński RM
Epilepsia; 2020 Oct; 61(10):2119-2128. PubMed ID: 32929733
[TBL] [Abstract][Full Text] [Related]
13. Structural Exploration of Quinazolin-4(3H)-ones as Anticonvulsants: Rational Design, Synthesis, Pharmacological Evaluation, and Molecular Docking Studies.
Ugale VG; Bari SB
Arch Pharm (Weinheim); 2016 Nov; 349(11):864-880. PubMed ID: 27680868
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and anticonvulsant activity of new hybrid compounds derived from N-phenyl-2-(2,5-dioxopyrrolidin-1-yl)-propanamides and -butanamides.
Kamiński K; Rapacz A; Filipek B; Obniska J
Bioorg Med Chem; 2016 Jul; 24(13):2938-2946. PubMed ID: 27211245
[TBL] [Abstract][Full Text] [Related]
15. Antiseizure drug efficacy and tolerability in established and novel drug discovery seizure models in outbred vs inbred mice.
Koneval Z; Knox KM; Memon A; Zierath DK; White HS; Barker-Haliski M
Epilepsia; 2020 Sep; 61(9):2022-2034. PubMed ID: 32757210
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional Hybrid Compounds Derived from 2-(2,5-Dioxopyrrolidin-1-yl)-3-methoxypropanamides with Anticonvulsant and Antinociceptive Properties.
Abram M; Zagaja M; Mogilski S; Andres-Mach M; Latacz G; Baś S; Łuszczki JJ; Kieć-Kononowicz K; Kamiński K
J Med Chem; 2017 Oct; 60(20):8565-8579. PubMed ID: 28934547
[TBL] [Abstract][Full Text] [Related]
17. Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.
Rapacz A; Kamiński K; Obniska J; Koczurkiewicz P; Pękala E; Filipek B
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):567-579. PubMed ID: 28188357
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Anticonvulsant, and Antinociceptive Activity of New 3-(2-Chlorophenyl)- and 3-(3-Chlorophenyl)-2,5-dioxo-pyrrolidin-1-yl-acetamides.
Góra M; Czopek A; Rapacz A; Gębska A; Wójcik-Pszczoła K; Pękala E; Kamiński K
Molecules; 2021 Mar; 26(6):. PubMed ID: 33809109
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological activity of new amides derived from 3-methyl-3-phenyl-2,5-dioxo-pyrrolidin-1-yl-acetic acid.
Obniska J; Rapacz A; Rybka S; Powroźnik B; Pękala E; Filipek B; Żmudzki P; Kamiński K
Eur J Med Chem; 2015 Sep; 102():14-25. PubMed ID: 26241874
[TBL] [Abstract][Full Text] [Related]
20. In Vivo and In Vitro Characterization of Close Analogs of Compound KA-11, a New Antiseizure Drug Candidate.
Andres-Mach M; Zagaja M; Szala-Rycaj J; Szewczyk A; Abram M; Jakubiec M; Ciepiela K; Socała K; Wlaź P; Latacz G; Khan N; Kaminski K
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
